We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CBER Five-Year Research Plan Aims To Speed Adverse Event Analysis
CBER Five-Year Research Plan Aims To Speed Adverse Event Analysis
May 18, 2012
CBER plans to rely heavily on the FDA’s new “Mini-Sentinel” surveillance pilot program to improve its ability to identify low-frequency adverse events involving licensed products.